IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NYXH

Balance Sheet

(in millions EUR)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q3 2022Q4 2021
Cash & Equivalents30.0022.7334.1927.7221.6116.6017.8989.885.86
Inventory4.665.334.725.103.321.150.880.59--
Total Current Assets61.2155.1198.0889.6868.3591.33100.26119.34--
Total Non-current Assets57.2661.3660.3258.5655.8151.0945.8144.73--
Total Assets118.47116.47158.41148.23124.16142.41146.07164.07--
Total Current Liabilities48.9620.9521.5316.3814.4415.2414.9120.01--
Total Non-current Liabilities20.3822.1323.6211.7111.6911.6010.8310.99--
Total Liabilities69.3443.0745.1528.0926.1426.8425.7531.00--
Retained Earnings(306.03)(260.21)(217.73)(185.54)(160.83)(142.52)(118.21)(105.06)--
Total Stockholder Equity49.1373.40113.25120.1498.02115.58120.32133.07--
← Scroll for more columns →

Income Statement

(in millions EUR) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q3 2022
Gross Profit0.850.490.690.12
Research & Development10.067.476.614.22
Selling, General & Admin10.676.386.194.76
Total Operating Expenses*20.7013.8012.578.90
Operating Income(19.85)(13.31)(11.88)(8.78)
Pretax Income(20.33)(12.68)(11.87)(6.17)
Tax Provision0.280.440.930.07
Net Income(20.61)(13.12)(12.80)(6.24)
Basic EPS(0.55)(0.43)(0.45)(0.24)
Diluted EPS(0.55)(0.43)(0.45)(0.24)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions EUR)
MetricQ2 2025Q2 2024Q2 2023Q3 2022
Operating Cash Flow(35.25)(23.59)(22.48)(18.39)
Investing Cash Flow26.79(15.56)3.89(31.64)
Financing Cash Flow(1.20)44.9817.80(0.76)
← Scroll for more columns →